Financial Data and Key Metrics Changes - The Oncology Institute achieved its first profitable quarter as a public company from an adjusted EBITDA perspective in Q4 2025, with a revenue increase of approximately 28% year-over-year, surpassing $500 million for the first time [4][5] - Total revenue for Q4 2025 was $142 million, representing a 41.6% year-over-year growth, driven by patient growth and pharmacy contributions [20] - Adjusted EBITDA was $147,000 in Q4 2025, improving from -$7.8 million in Q4 2024 [24] Business Line Data and Key Metrics Changes - The fee-for-service business grew 9% year-over-year from $136.2 million to $148.5 million, while the capitation business grew 17.2% year-over-year from $68.7 million to $80.5 million [17] - Pharmacy revenue grew 49.6% year-over-year from $179.9 million to $269.2 million, primarily due to improved prescription attachment rates [18] Market Data and Key Metrics Changes - The company expanded its capitated footprint by initiating 9 new capitated contracts during 2025, adding approximately 260,000 patient lives under management [5] - The partnership with Elevance Health in Florida ramped up, with approximately 70,000 lives under capitated arrangements by the end of 2025 [8] Company Strategy and Development Direction - The Oncology Institute aims to continue scaling its value-based care platform and expects over 80% growth in capitated revenue for 2026 [11] - The company plans to launch a proprietary new network portal in Q2 2026 to enhance engagement with providers and improve operational efficiencies [11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to grow and manage industry-leading medical loss ratio (MLR) performance under its delegated capitation model [13] - The company views the potential lower rate environment for Medicare Advantage as a tailwind, as it allows for proactive engagement with payers seeking to improve care delivery [74] Other Important Information - The company reduced debt on its convertible preferred note by $24 million and ended the year with $33.6 million in cash [8] - The leadership team was strengthened with new appointments, including a Chief Clinical Officer and a Chief Administrative Officer [10] Q&A Session Summary Question: What drove the higher dispensing revenue in Q4? - The strong performance was driven by operational execution in mitigating leakage of prescriptions and strong patient encounter growth related to capitated contract growth [31] Question: Will the Elevance contract double in size in 2026? - Yes, that is the goal [32] Question: What is the size of the total addressable market for Elevance or Humana? - There is significant opportunity for growth, with many multiples of current capitated revenue available in the market [35] Question: Will there be a dip in profit margins due to ramping up capitated contracts? - A slight increase in MLR is expected for delegated contracts, but overall gross margins should not dip [44] Question: Can you provide details on the number of affiliated clinics? - The network has grown to over 200 providers in Florida, bringing the total to close to 300 combined [46] Question: What are the expectations for SG&A in 2026? - Improvements in SG&A as a percentage of revenue are expected, but not to the same degree as in 2025 due to growth investments [65]

Financial Data and Key Metrics Changes - The company ended Q4 with a record net new subscription ARR growth of $115 million, significantly exceeding expectations [5] - Subscription ARR reached $1.46 billion, growing 34% year-over-year [20] - Subscription revenue was $365 million, up 50% year-over-year [22] - Free cash flow for Q4 was $70 million, with total free cash flow for fiscal 2026 at $238 million, compared to $22 million for fiscal 2025 [25][29] - Non-GAAP gross margin improved to 84% in Q4 from 80% in the previous year [23] Business Line Data and Key Metrics Changes - The adoption of Rubrik Security Cloud resulted in $1.29 billion of cloud ARR, up 48%, representing 88% of subscription ARR [21] - The number of customers contributing $100,000 or more in subscription ARR rose 25% to 2,805, now representing 87% of subscription ARR [22] - The identity line of business saw rapid growth, crossing 900 customers in just three to four quarters [49] Market Data and Key Metrics Changes - Revenue from the Americas grew 45% to $268 million, while revenue from outside the Americas grew 51% to $109 million [23] - The company reported a strong subscription net retention rate of over 120% in Q4, with expansion through additional security products contributing over 45% to this rate [21] Company Strategy and Development Direction - The company is focused on advancing its mission to secure and accelerate the world's AI transformation, with a strong emphasis on cyber resilience and identity protection [19][50] - Investments will continue in R&D to accelerate innovation in data security and AI, as well as in go-to-market strategies targeting high ROI regions and verticals [26][29] - The launch of Rubrik Agent Cloud aims to provide dynamic real-time AI agent controls to accelerate enterprise AI transformation [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the robust cyber resilience market and the company's differentiated technology platform, expecting strong growth in subscription ARR [25][29] - The company anticipates continued operational investments and a focus on scaling emerging products like the Identity Resilience Platform and Rubrik Agent Cloud [26][29] - Management highlighted the importance of data integrity and availability as foundational for AI transformation, asserting that Rubrik's role will only grow with the rise of AI [71] Other Important Information - The company reported a competitive win rate exceeding 90% in Q4, indicating strong market positioning against legacy vendors [7][85] - The company is actively engaging with customers regarding the emerging sovereign cloud opportunity, which is still evolving [41][42] Q&A Session Summary Question: Insights on Agent Cloud POCs with Fortune 500 and AI startups - Management indicated that customers are focused on understanding the number of agents in their systems and how to control them, with real-time dynamic guardrails being a priority [33][34] Question: Customer impetus for Rubrik Sovereign Cloud - Management noted that geopolitical concerns have driven countries to seek sovereign data solutions, with significant product adaptations required [40][42] Question: Concerns about AI impacting core business value - Management reassured that Rubrik's complex software is not easily replicable by AI, emphasizing the importance of data infrastructure for AI transformation [70][72] Question: Dynamics of Q4 performance and Q1 guidance - Management clarified that while Q4 was strong, they do not expect significant pull-forward effects impacting Q1 guidance [80] Question: Competitive environment and legacy vendor displacement - Management stated that there is still a large opportunity for legacy replacement, with a high win rate against data protection vendors [85]

Financial Data and Key Metrics Changes - Adobe achieved revenue of $6.4 billion in Q1 FY 2026, representing an 11% year-over-year growth [11][32] - GAAP earnings per share (EPS) for the quarter was $4.60, and non-GAAP EPS was $6.06, reflecting 11% and 19% year-over-year growth, respectively [11][32] - Total Adobe ending Annual Recurring Revenue (ARR) reached $26.06 billion, growing 10.9% year-over-year [32] - Cash flows from operations in the quarter were a record $2.96 billion, with ending cash and short-term investments at $6.89 billion [33] Business Line Data and Key Metrics Changes - Subscription revenue for business professionals and consumers was $1.78 billion, increasing 15% year-over-year [15][33] - Creative and marketing professionals' subscription revenue was $4.39 billion, growing 11% year-over-year [17][33] - Monthly active users (MAU) for Acrobat and Express grew approximately 20% year-over-year, with Creative Premium MAU crossing 80 million, growing 50% year-over-year [35][14] Market Data and Key Metrics Changes - Adobe's end-to-end solutions achieved over 30% year-over-year growth in Adobe Experience Platform (AEP) and Apps, as well as Adobe GenStudio [10][32] - The company serves 99 of the Fortune 100 and is the digital platform of choice for chief marketing officers [24] Company Strategy and Development Direction - Adobe is focusing on an AI-driven business model, targeting business professionals and consumers through AI-infused product offerings [7][11] - The company aims to empower everyone to create, leveraging creativity as a core element of its strategy [6][12] - New products include Adobe Acrobat Studio, Adobe Firefly, and Adobe GenStudio, with a strong emphasis on customer-centric product strategy [8][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in Adobe's ability to drive growth through innovation and customer-centric strategies, particularly in the AI space [11][40] - The transition to an AI-driven business is expected to enhance customer engagement and drive future revenue growth [11][39] - Management anticipates continued strength in core products and enterprise demand for customer experience orchestration solutions [38][39] Other Important Information - The company is undergoing a leadership transition, with Shantanu Narayen stepping down as CEO after 18 years [5][6] - Adobe's AI-first applications have seen ARR more than triple year-over-year, indicating strong market demand [11][36] Q&A Session Summary Question: What is the board looking for in Adobe's next CEO? - The next CEO should focus on product innovation and capitalize on the opportunities presented by AI across creativity and marketing [49][50] Question: Can you discuss the revenue acceleration observed this quarter? - Revenue acceleration is attributed to strong user adoption and the successful integration of AI into existing workflows, offsetting declines in the traditional stock business [59][61] Question: What initiatives are being taken to drive future ARR growth? - The company is focused on increasing monthly active users and enhancing product offerings, which are expected to translate into future ARR growth [68][72]

Financial Data and Key Metrics Changes - Revenue from continuing operations increased by 3.1% in Q4 2025 compared to Q4 2024, while consolidated adjusted EBITDA rose by 7.8% [9][18] - For the full year 2025, revenue was $54.9 million, up from $52.2 million in 2024, and consolidated net income increased to $2.9 million from a loss of $5.8 million in 2024 [21][22] Business Line Data and Key Metrics Changes - System-wide sales decreased by 3.9% to $130 million in Q4 2025, with comp sales down 3.8% [18] - The total clinic count at year-end was 960, down from 967 the previous year, with 29 new clinics opened and 41 refranchised during 2025 [19] Market Data and Key Metrics Changes - The company is focusing on improving new patient acquisition through enhanced marketing strategies, shifting from local to national advertising to increase brand awareness [12][34] - New patient acquisition trends have shown improvement each month since the launch of the new marketing initiatives, although they remain lower than the previous year [14][54] Company Strategy and Development Direction - The company is on track to complete the first phase of its transformation journey, Joint 2.0, by the end of 2025, transitioning to a pure-play franchisor model [5][27] - Future growth strategies include expanding operations into new channels and markets, focusing on integrated treatments and leveraging data from wearable technology [28] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving long-term goals despite current challenges, emphasizing the importance of improving marketing effectiveness and patient retention [27][62] - The company anticipates that the second half of 2026 will show improved comp sales due to easier comparisons and traction from current initiatives [51][66] Other Important Information - The company repurchased 1.1 million shares for $9 million in Q4 2025, with a total of 1.3 million shares repurchased for $11.3 million throughout the year [9][22] - The company expects system-wide sales for 2026 to range from $519 million to $552 million, with comp sales projected between -3% to 3% [22] Q&A Session Summary Question: Can you share the attrition and new patient add metrics? - Management noted that new patient flow has been the weakest component of active member growth, but early signs from new marketing efforts are positive [31][32] Question: How are you evolving marketing initiatives for 2026? - The focus remains on shifting investment from local to national marketing, improving creative messaging, and addressing changes in search behaviors due to AI [34][35] Question: How did the three-tiered pricing pilot go? - The $10 pricing increase showed more benefit compared to the $2 increase, and further testing is ongoing before broader rollout [38][39] Question: What specific leading indicators give confidence that comps will improve in 2026? - Management highlighted early signs of improvement in leads and new patients, with expectations for better performance in the second half of the year [51][52] Question: Does your guidance include a pricing increase? - No, the guidance does not include any pricing increase as the results from recent tests were still uncertain [67]

Financial Data and Key Metrics Changes - Revenue from continuing operations increased by 3.1% in Q4 2025 compared to Q4 2024, while consolidated adjusted EBITDA rose by 7.8% [9][18] - For the full year 2025, revenue was $54.9 million, up from $52.2 million in 2024, and consolidated net income increased to $2.9 million from a loss of $5.8 million in 2024 [21][24] - Adjusted EBITDA from consolidated operations improved by 14% to $13 million for the full year [21] Business Line Data and Key Metrics Changes - System-wide sales decreased by 3.9% to $130 million in Q4 2025, while comp sales were down 3.8% [18] - The total clinic count at year-end was 960, down from 967 clinics the previous year, with 29 new clinics opened and 41 refranchised during 2025 [19] Market Data and Key Metrics Changes - The company is focusing on improving new patient acquisition through enhanced marketing strategies, shifting from local to national advertising to increase brand awareness [12][35] - The marketing initiatives have shown early signs of improvement in lead generation and new patient acquisition, although the overall new patient count remains lower than last year [54][61] Company Strategy and Development Direction - The company is on track to complete the first phase of its transformation journey, Joint 2.0, by the end of 2025, transitioning to a pure-play franchisor model [5][28] - Future growth strategies include expanding operations into new channels and markets, focusing on health trends and integrating technology into treatment plans [29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in improving financial performance through ongoing marketing initiatives and refranchising efforts, with expectations for better comp sales in the second half of 2026 [51][66] - The company anticipates that the completion of refranchising will lead to a more profitable operational model in 2026 [24][25] Other Important Information - The company repurchased 1.1 million shares for $9 million in Q4 2025, with a total of 1.3 million shares repurchased for $11.3 million throughout the year [9][23] - Unrestricted cash at the end of Q4 2025 was $23.6 million, down from $25.1 million the previous year [22] Q&A Session Summary Question: Can you share the attrition and new patient add metrics? - Management noted that new patient flow has been the weakest component of active member growth, but conversion and attrition rates have slightly improved compared to last year [33][34] Question: How are you evolving marketing initiatives for 2026? - The focus remains on shifting investment from local to national marketing, enhancing creative messaging, and addressing changes in search behaviors due to AI [35][36] Question: How did the three-tiered pricing pilot go? - The $10 pricing increase showed more benefit compared to the $2 increase, and further testing is ongoing before broader rollout [39][40] Question: How did comp sales progress throughout the quarter? - Comp sales were down the most in November but improved in December, with expectations for incremental improvement in early 2026 [46][66] Question: What specific leading indicators give confidence that comps will improve in 2026? - Management highlighted early signs of improvement in lead generation and SEO effectiveness, which are expected to contribute to better comp sales in the second half of 2026 [51][54] Question: Does your guidance include a pricing increase? - The guidance does not currently include any pricing increases as the results from recent tests are still being evaluated [67]

Financial Data and Key Metrics Changes - For the full year of 2025, the company generated $311.1 million in revenue and $41.4 million of Adjusted EBITDA, with total revenue for Q4 2025 at $74.7 million, down from $79.6 million in the prior year period [25][26] - Adjusted gross margin for Q4 2025 was 53.5%, compared to 46.6% in the prior year period, while for the full year, it was 51.1% driven by technology gross margin of 67.4% and professional services gross margin of 18.3% [27] - Adjusted operating expenses for Q4 2025 were $26.2 million, representing 35% of revenue, down from $29.2 million or 37% of revenue in Q4 2024 [28] Business Line Data and Key Metrics Changes - Technology revenue for Q4 2025 was $51.9 million, while professional services revenue was $22.8 million, with the decline in professional services revenue attributed to reductions in FTE service offerings and exiting unprofitable pilot arrangements [25][26] - For the full year, technology revenue increased 7% year-over-year to $208.3 million, while professional services revenue declined 8% [27] Market Data and Key Metrics Changes - The company finished the year with 32 net new logos, ahead of the target of 30 but below the initial expectation of 40 [25] - The tech plus TAMS dollar-based retention closed the year at 93% [25] Company Strategy and Development Direction - The company is focused on long-term success, emphasizing a back-to-basics approach to deliver measurable outcomes across cost efficiency, clinical improvement, and consumer experience [10][17] - Plans include tightening leadership focus, improving operational rigor, and simplifying the commercial story to better articulate the value proposition [12][16] - The company aims to strengthen and simplify its commercial engine to drive technology ARR bookings and improve retention through predictable migrations [19][21] Management's Comments on Operating Environment and Future Outlook - Management noted that the market is under pressure, with clients needing to manage costs while maintaining clinical quality [56] - The company is currently in an assessment mode to best position itself for shareholder value, with no immediate plans for selling the company [44][46] - The first quarter of 2026 is expected to see revenue of $68 million to $70 million and Adjusted EBITDA of $7 million to $8 million, with anticipated challenges due to migration-related revenue declines [33][35] Other Important Information - The company incurred impairment charges on goodwill and intangible assets of $110.2 million during 2025, primarily due to a decrease in market cap and forecast revisions [31] - The company is reviewing its cost structure to ensure strategic capital allocation and is focused on expanding technology bookings and margins [13][22] Q&A Session Summary Question: Does the strategic review include the possibility of selling the company? - Management is focused on positioning the company for long-term success and creating shareholder value, with no definitive answer on selling the company at this time [44][46] Question: Can you elaborate on the transition impact regarding the $52 million in data platform revenue? - The $52 million encompasses both integrated applications and data platform infrastructure, with the latter experiencing the highest pressure during the migration [50][51] Question: What insights were gained regarding bookings and demand environment in Q4? - The market is in need of better cost management and clinical quality, with significant pressure on profitability for provider clients [56] Question: How does the company plan to maintain client relationships amid data platform disintermediation? - The company aims to retain application relationships while addressing the challenges posed by data platform infrastructure changes [52][66] Question: What is the expected impact of the $12.5 million in ARR churn on 2026? - Approximately 75% of the $12.5 million is expected to impact 2026, with more details to be provided in future guidance [84][85]

Financial Data and Key Metrics Changes - In Q4, the company delivered $18.3 million in bookings, near the high end of the guided range, with strong contributions from IP products and TCAD solutions [14] - Revenue reached $18.3 million in the quarter, above the high end of the guided range, with TCAD and IP revenue growing 34% and almost 3x respectively [14][15] - GAAP gross margin in Q4 was 83.3%, and non-GAAP gross margin was 85.6%, reflecting a sequential increase of roughly five full points [15] - GAAP operating loss improved to a $6.8 million loss, while non-GAAP operating loss was just over $1 million, ahead of expectations [17][18] Business Line Data and Key Metrics Changes - TCAD business saw a 70% sequential increase in bookings to $9.2 million and a 34% sequential increase in revenue to $8.7 million, driven by the adoption of the AI-driven FTCO solution [6][14] - The semiconductor IP business delivered record revenue and bookings of over $5 million, significantly boosted by the Mixel acquisition [7][14] - EDA bookings and revenue declined significantly in Q4, with bookings just under $4 million and revenue of $4.4 million, following record numbers in Q3 [9][15] Market Data and Key Metrics Changes - The APAC region contributed significantly to growth, accounting for 57% of total revenue in Q4, driven by the FTCO solution [15] - The MIPI PHY market is valued at over $300 million per year, with the company holding a relatively modest share, indicating potential for growth [7] Company Strategy and Development Direction - The company is focused on accelerating its AI-driven solutions, particularly in semiconductor manufacturing process development, which is expected to be a long-term growth driver [5][12] - The restructuring efforts have improved gross margins and increased R&D capacity, with a commitment to reducing annualized non-GAAP operating expenses by at least $20 million [17][19] - The company anticipates steady growth in the IP business, with expectations for significant growth in TCAD as contract renewals increase [11][12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the turnaround plan, noting that the execution is ahead of expectations and positioning the company for a faster recovery [4][12] - The company expects to approach operating cash flow breakeven in Q2 and to achieve positive operating cash flow in Q3 [18][19] - Management highlighted the importance of AI in transforming semiconductor manufacturing processes, which is expected to enhance yields and throughput [12][24] Other Important Information - The company has executed cost reductions ahead of expectations, leading to a significant decline in the underlying burn rate [18] - The guidance for Q1 2026 includes bookings and revenue expectations of between $15 million and $19 million, with a non-GAAP gross margin around 85% [19] Q&A Session Summary Question: Growth priorities and execution - Management noted the need for financial flexibility and the successful execution of the cost reduction program, which has improved morale and opened new opportunities [22][24] Question: Revenue recognition for FTCO deal - A significant portion of the FTCO revenue was recognized in Q4, with the remainder to be recognized over the contract term [27][28] Question: Adoption process for FTCO - The efficiency in closing and ramping FTCO customers is expected to improve, with a growing pipeline of customers recognizing the value of AI in process development [35] Question: Bookings by segment in Q1 - Continued strength in TCAD is anticipated, with IP expected to remain stable and EDA showing flat performance [36] Question: Growth from Mixel acquisition - The Mixel acquisition is expected to contribute significantly to growth, with double-digit revenue growth anticipated in the current calendar year [46][52]

Financial Data and Key Metrics Changes - In Q4 2025, the company reported revenue of $6.2 million, exceeding guidance, compared to $6.7 million in Q4 2024, reflecting a decrease due to the exit of lower-margin business [7][11] - Q4 GAAP gross margin improved to 18.1% from -14.9% in Q4 2024, while non-GAAP gross margin rose to 25.6% from -5.2% [7][11] - For fiscal year 2025, revenue was $21.5 million, down $5.1 million from the previous year, with GAAP gross margin at 6.1% and non-GAAP gross margin at 14.3%, both showing significant improvement from fiscal year 2024 [11][12] Business Line Data and Key Metrics Changes - The transition of production from Singapore to Thailand has structurally reduced costs and improved manufacturing efficiency, contributing to margin expansion [5][18] - The company completed its transition to a pure-play IoT company, enhancing focus on high-value IoT opportunities [18][19] Market Data and Key Metrics Changes - The company is scaling production to support IFCO's demand for BLE smart labels, with a capacity target of 100 million units per year [32][24] - The customer-driven opportunities in the pipeline are approximately 25% in healthcare, 25% in logistics, and 25% in food and beverage [36] Company Strategy and Development Direction - The company is focused on its Perform, Accelerate, and Transform strategy, aiming to strengthen core business, drive operational efficiency, and expand margins [3][17] - Strategic partnerships and new product development are key components of the Accelerate strategy, with significant progress in BLE technology and multi-component manufacturing [22][23] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, highlighting tangible progress made in 2025 and a strong operational foundation for 2026 [17][29] - The company anticipates Q1 2026 sales between $6.7 million and $7.2 million, reflecting a 26%-35% increase over Q1 2025 [15][16] Other Important Information - The company exited Q4 2025 with $128.9 million in cash equivalents, indicating a strong balance sheet [13][14] - The board has taken shareholder-friendly actions, including the declassification of the board and the addition of a financial expert [28][29] Q&A Session Summary Question: Insights on the IFCO opportunity and revenue potential - Management is excited about the IFCO project, with plans to scale up to 100 million units per year, and while specific pricing and gross margins were not disclosed, it is expected to be higher than average product pricing [32][33] Question: Breakdown of the new opportunity pipeline by end market - The current pipeline consists of approximately 25% healthcare, 25% logistics, and 25% food and beverage opportunities [36] Question: Contribution of gross margin drivers in 2026 - Management anticipates near-term variability in gross margins as they scale for the IFCO project and onboard a new customer, but expects overall margin expansion as they progress through 2026 [45][48]

Financial Data and Key Metrics Changes - Revenue for the fourth quarter was $58.9 million, a 16% decrease year-over-year and a sequential decrease of 7% compared to the third quarter [14] - Gross profit dollars totaled $9.1 million, a decline of 15% year-over-year and a sequential decline of 21%, resulting in a gross margin of 15.5% [16] - SG&A expenses were $7.7 million, a 24% reduction year-over-year and a 17% reduction sequentially [20] Business Line Data and Key Metrics Changes - The decline in revenue was primarily driven by clients in the industrial end market and the divested mall-related business, accounting for a $10.7 million reduction in quarterly revenue [14] - Despite challenges, the remaining two-thirds of the business saw modest growth of $7.4 million, or about 5% [15] - New business wins and wallet share initiatives launched in the fourth quarter are expected to contribute positively in 2026 [15][18] Market Data and Key Metrics Changes - The overall pipeline remains healthy, but economic uncertainty has led to decision delays among potential clients [7] - The industrial end market continues to face challenges, impacting volumes from industrial customers [5][14] Company Strategy and Development Direction - The company is focused on operational excellence initiatives to drive efficiencies and improve financial performance as market conditions normalize [8][13] - There is an emphasis on expanding wallet share with existing customers and onboarding new clients to enhance revenue streams [10][13] - The company aims to reduce debt and improve cash generation while navigating a challenging operating environment [23][24] Management's Comments on Operating Environment and Future Outlook - Management acknowledged that 2025 was a challenging year due to volume declines from the industrial end market, but expressed confidence in future recovery as macroeconomic conditions improve [12][26] - The company is committed to controlling operational efficiencies and costs despite external challenges [30] Other Important Information - The company divested an underperforming business, complicating year-over-year comparisons [12] - Cash generation improved, with $1 million generated from operations and $1.7 million of free cash flow in the fourth quarter [21] Q&A Session Summary Question: Update on KPIs and operational efficiency initiatives - Management confirmed that KPIs and operational efficiency initiatives are on track, with positive trending despite volume challenges [29][30] Question: Health of the vendor network - Management reported improved relationships with vendors, with lower service disruptions and costs associated with those disruptions at historic lows [31][32] Question: Opportunities for cross-selling and market share expansion - Management indicated that if industrial clients expand operations, the company stands to benefit due to strong relationships with these clients [35][36]

Financial Data and Key Metrics Changes - Fourth quarter net revenue was $118 million, a decline of 19% year-over-year compared to $446.1 million in the prior year period [16] - Full year net revenue was $319.9 million, a decline of 14% year-over-year compared to $372.8 million in 2024 [17] - Fourth quarter gross margins reached 40.1%, a year-over-year improvement of nearly 310 basis points [16] - Full year gross margins of 37.3% represented an improvement of 270 basis points year-over-year, marking the highest annual level since 2018 [18] - Net income for the fourth quarter was $17.6 million, compared to $20.1 million in the prior year period [16] - Full year net income was $15.7 million, representing a 3% year-over-year decline compared to $16.2 million in 2024 [18] Business Line Data and Key Metrics Changes - The company gained share in its core Turtle Beach headset brand despite overall market softness [6] - The racing sim product line is performing well, with share gains year-over-year [27] - The company plans to launch over 50% more new products in 2026 compared to 2025, with innovations across all categories [8][29] Market Data and Key Metrics Changes - The gaming accessories market experienced unexpected softness, particularly in North America [5] - The company anticipates a strong replacement cycle driven by major game releases, including Grand Theft Auto VI, scheduled for late 2026 [7][8] - The industry is entering a console refresh cycle, expected to drive increased hardware adoption and accessory demand [8] Company Strategy and Development Direction - The company implemented comprehensive cost optimization initiatives that drove gross margin expansion [9] - A strategic refinancing of debt was completed, lowering the base interest rate on the term loan by approximately 450 basis points [11] - The company is actively assessing bolt-on acquisitions to complement its growing platform, although no new deals have been announced [13][14] - The focus for 2026 is on leveraging operational gains and capitalizing on improving market conditions [24] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the trajectory of the business moving into 2026, despite current market headwinds [8][20] - The company expects full year 2026 revenue to be in the range of $335 million-$355 million, representing 8% growth at the midpoint compared to 2025 [21] - Management believes the current equity market does not appropriately price the stock, leading to potential increased share repurchases [15] Other Important Information - The company repurchased approximately 1.35 million shares for approximately $19 million in 2025, with a new 2-year $75 million share repurchase program authorized [12][19] - The balance sheet remains solid with a cash position of $17 million as of December 31 [18] Q&A Session Summary Question: How are the racing sim products performing and what about the 50% more products for 2026? - Management noted that racing sim products are doing well with share gains and that the 50% increase in SKUs will span across all categories, with exciting innovations coming soon [27][29] Question: Can you provide a revenue range related to GTA VI for your guidance? - Management confirmed that the second half of the year is expected to be strong, with GTA VI's launch in Q4 being a significant driver of growth [32][33] Question: What are the expectations for gross margin versus OpEx in 2026? - Management expects continued improvements in gross margin due to prior tariff mitigations and product changes, while OpEx structure will remain similar to 2025 [39] Question: What is the current state of retail inventories? - Management indicated that retail inventories ended the year in a lighter position due to softer demand, but they do not anticipate further declines in channel inventories [51] Question: What is the company's leverage threshold for potential borrowing capacity expansion? - Management is comfortable with a leverage range of 2-2.5 and is exploring options to obtain new financing for increased flexibility [59] Question: What are the drivers of optimism beyond GTA VI? - Management highlighted multiple factors including the overdue accessories replacement cycle, new product innovations, and the upcoming console refresh cycle as drivers of optimism [66]